NasdaqGM - Delayed Quote USD

Prime Medicine, Inc. (PRME)

1.2700
-0.0700
(-5.22%)
At close: May 13 at 4:00:01 PM EDT
1.2900
+0.02
+(1.57%)
After hours: May 13 at 7:29:23 PM EDT
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
3,846
2,983
0
0
0
Operating Expense
210,364
205,450
191,292
116,544
84,474
Operating Income
-206,518
-202,467
-191,292
-116,544
-84,474
Net Non Operating Interest Income Expense
4,028
3,522
2,811
--
--
Other Income Expense
345
3,063
-9,931
-6,225
-81,379
Pretax Income
-202,145
-195,882
-198,412
-122,769
-165,853
Tax Provision
-134
0
-279
-948
-486
Net Income Common Stockholders
-202,011
-195,882
-198,133
-142,014
-184,119
Diluted NI Available to Com Stockholders
-202,011
-195,882
-198,133
-142,014
-184,119
Basic EPS
-1.61
--
-2.18
-4.19
-2.56
Diluted EPS
-1.61
--
-2.18
-4.19
-2.56
Basic Average Shares
125,204.9590
--
90,969.3270
33,891.2640
71,795.5140
Diluted Average Shares
125,204.9590
--
90,969.3270
33,891.2640
71,795.5140
Total Operating Income as Reported
-206,518
-202,467
-204,792
-116,544
-84,474
Total Expenses
210,364
205,450
191,292
116,544
84,474
Net Income from Continuing & Discontinued Operation
-202,011
-195,882
-198,133
-121,821
-165,367
Normalized Income
-199,305.7944
-195,397
-182,273.3327
-113,749.8960
-164,977.1730
Interest Income
4,028
3,522
2,811
--
--
Net Interest Income
4,028
3,522
2,811
--
--
EBIT
-206,518
-202,467
-191,292
-116,544
-84,474
EBITDA
-200,005
-196,339
-186,639
-114,320
-83,906
Reconciled Depreciation
6,513
6,128
4,653
2,224
568
Net Income from Continuing Operation Net Minority Interest
-202,011
-195,882
-198,133
-121,821
-165,367
Total Unusual Items Excluding Goodwill
-2,707
-485
-15,882
-8,128
-391
Total Unusual Items
-2,707
-485
-15,882
-8,128
-391
Normalized EBITDA
-197,298
-195,854
-170,757
-106,192
-83,515
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
-1.7944
0
-22.3327
-56.8960
-1.1730
12/31/2021 - 10/20/2022

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

BEAM Beam Therapeutics Inc.
18.05
-1.04%
 
VERV Verve Therapeutics, Inc.
4.1600
-4.37%
 
CRBU Caribou Biosciences, Inc.
0.7828
-4.31%
 
NTLA Intellia Therapeutics, Inc.
8.32
-2.69%
 
SANA Sana Biotechnology, Inc.
1.7950
-10.25%
 
EDIT Editas Medicine, Inc.
1.5000
-2.60%
 
ABSI Absci Corporation
2.9600
+1.02%
 
FATE Fate Therapeutics, Inc.
1.0000
-6.54%
 
ALLO Allogene Therapeutics, Inc.
1.1300
-3.42%
 
WVE Wave Life Sciences Ltd.
6.39
-3.18%